forstoringsglas

Search results

Vinge advises Azelio in connection with its capital raising and listing on Nasdaq First North

Vinge has advised Azelio AB (publ) (“Azelio”) in connection with its capital raising and listing on Nasdaq First North.
December 10, 2018

Vinge advises Xspray Pharma in connection with a directed share issue

The board of directors of Xspray Pharma AB (publ) has resolved on a directed new issue of shares, whereby Xspray Pharma will raise proceeds of approximately SEK 92 million, before issue costs. 
December 10, 2018

Vinge advises Biotage in connection with its acquisition of PhyNexus

Vinge advises Biotage AB (publ) (“Biotage”), listed on Nasdaq Stockholm, in connection with its acquisition of PhyNexus, Inc. (“PhyNexus”), financed through a combination of newly issued shares and existing cash at hand.
December 06, 2018

Vinge assists Stendörren in connection with EQT Real Estate II’s cash offer to the shareholders in Stendörren

Vinge has assisted Stendörren Fastigheter AB (publ) (“Stendörren”) in connection with EQT Real Estate II’s, through Chicago Holding AB (“Chicago Holding”), cash offer to the shareholders in Stendörren.
December 05, 2018

Vinge advises Vicore Pharma in connection with a directed share issue

The board of directors of Vicore Pharma has resolved, subject to the approval by an extraordinary general meeting, on a directed new issue of shares, whereby Vicore Pharma will raise proceeds of approximately SEK 160 million before issue costs. 
December 04, 2018

Vinge assists Vostok New Ventures Ltd in connection with an investment in Voi

Vinge has assisted Vostok New Ventures Ltd (“Vostok”) in connection with an investment by a number of investors in Voi Technology AB, a company that provides an electric scooter sharing service.
November 27, 2018

Vinge advised Equinor in connection with its investment in Medfield Diagnostics

Vinge advised Equinor Technology Ventures AS (”Equinor”) in connection with its acquisition in Medfield Diagnostics Aktiebolag (publ) (“Medfield”).
November 21, 2018
November 20, 2018

Vinge advises Hansa Medical in connection with a directed share issue

The board of directors of Hansa Medical has resolved on a directed new issue of shares, whereby Hansa Medical will raise proceeds of approximately SEK 453 / USD 50 million, before issue costs.
November 15, 2018

Vinge advises Irisity AB (publ)

Vinge has advised Irisity AB (publ), Nasdaq First North, in connection with a directed new issue of shares to Nordic institutional and private investors.
November 10, 2018

Vinge assists William Hill on its offer for Mr Green & Co

William Hill has launched a recommended cash offer to the shareholders in Mr Green & Co, MRG (Nasdaq Stockholm). The total offer value for all shares in MRG amounts to approximately SEK 2.819 billion.     
October 31, 2018

Vinge advised Ysios Capital, OrbiMed and others in connection with their investment in Galecto Biotech

Galecto Biotech AB, the developer of galectin modulators for the treatment of severe diseases, including fibrosis and cancer, has closed a €79 million financing co-led by Ysios Capital and OrbiMed.
October 29, 2018

Vinge has advised Bilia in connection with the issuance and repurchase of bonds

Vinge has advised Bilia AB (publ) in connection with the issue of new senior and non subordinated bonds with a framework amount of SEK 1 500 000 000 as well as the repurchase of SEK 500 000 000 of a previously issued senior and non subordinated bond with a maturity date in 2021.
October 09, 2018

Vinge has advised Transtema in conjunction with a rights issue

Vinge has advised Transtema in connection with a rights issue.
October 09, 2018

Vinge advises Klövern on its offer for Agora

Klövern AB (publ) has, through its indirectly wholly-owned subsidiary Dagon Sverige AB, made a public cash offer to the shareholders of A Group Of Retail Assets Sweden AB (publ) (Nasdaq First North).
October 09, 2018
Previous Next